Senior Director, National Accounts

🕒 il y a 9 jours

🍂 Massachusetts – Distant

🍂 Massachusetts – Remote

💵 $279 000 - $322 000 / an

⏰ Temps Plein

🟠 Senior

👔 Directeur

👻 Score fantôme 0%

Ce que ça veut dire : la probabilité que personne ne recrute vraiment pour cette offre.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Stoke Therapeutics

Site WebLinkedInTous les Emplois

201 - 500 employés

Fondée en 2017

🧬 Biotechnologie

💊 Pharmaceutique

🏥 Santé

💰 €125 000 000 Post-IPO Equity - Stoke Therapeutics en 2024-03

Biotechnology • Pharmaceuticals • Healthcare

Stoke Therapeutics est une entreprise de biotechnologie développant des thérapies à base d'ARN qui augmentent la production de protéines à partir des propres gènes du patient pour traiter des maladies génétiques rares. Sa plateforme TANGO (Targeted Augmentation of Nuclear Gene Output) utilise des oligonucléotides antisens pour réguler à la hausse l'expression génique dans les troubles d'haploinsuffisance. Les programmes principaux incluent STK‑001, une thérapie antisens en développement pour le syndrome de Dravet (haploinsuffisance SCN1A), et d'autres programmes axés sur la neurologie génétique et les indications de maladies rares.

Description

• Serve as the primary relationship owner for all accounts in the region • Lead and execute Stoke’s payer access strategy from the ground up • Engage targeted accounts and policy decision-makers to advance coverage timelines • Establish Stoke’s credibility and share clinical data with medical benefit policy decision-makers • Develop and execute pre-launch and launch-phase access strategies • Serve as strategic leader for key accounts in the region • Develop account-specific action plans to shorten the timeline from FDA approval to positive coverage determination • Build payer relationships before NDA submission • Develop multi-year access plans anticipating commercial cycles and competitive coverage shifts • Educate payers on clinical evidence, FDA labeling, treatment guidelines, and health-economic data • Monitor medical policy language and partner with Medical Affairs, HEOR, and Advocacy • Engage payer Medical Directors to obtain guidance letters or billing instructions pending permanent J code assignment • Influence policy decision-makers to achieve desired coverage outcomes • Serve as subject-matter expert on buy-and-bill reimbursement for miscellaneous J codes • Educate payer medical policy teams on claims submission, billing units, and NDC-to-J code crosswalks • Drive alignment across commercial and field medical teams and cross-functional departments • Coordinate field reimbursement and patient services to support approval success and timely patient access • Engage the Dravet syndrome patient and caregiver community • Conduct payer engagements in compliance with company SOPs, OIG guidelines, PhRMA Code, and applicable regulations • Navigate access challenges for a first-in-class disease-modifying ASO therapy

🎯 Exigences

• Bachelor’s degree required; advanced degree (MBA, MPH, PharmD) preferred • 15+ years in pharma/biotech • Minimum 10 years in payer account management with lead responsibility for one of the three large PBM and National accounts • Proven track record of achieving positive coverage outcomes for orphan designation or rare disease products on the medical benefit • Pre-launch payer strategy experience • Hands-on experience navigating a miscellaneous J code (J3490/J3590) environment, including transition to a permanent product-specific code • Strong command of managed care economics, formulary management, utilization management, and coverage policy development processes at national payers • Rare pediatric or neurological disease product launch experience; CNS or epilepsy payer experience a significant differentiator • Familiarity with disease-modifying therapy and gene testing reimbursement pathways as established according to payer policy • Experience at a startup or early commercial-stage biotech building its commercial infrastructure for the first time • Exceptional ability to influence across functions without direct authority • Passion for patient access and rare-disease impact • Proximity to a major US airport preferred • Approximately 50% travel

🏖️ Avantages

• Annual bonus • Equity participation • Medical insurance • Dental insurance • Vision insurance • Life insurance • Long- and short-term disability insurance • Paid parental leave • 401K plan with company match • Unlimited vacation time • Tuition assistance • Employee Stock Purchase Program (ESPP) • Flexible work arrangements • Employee-led Diversity, Inclusion, and Belonging (DIB) Committee

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV